AT1 receptor is present in glioma cells; its blockage reduces the growth of rat glioma
about
AGTR1 overexpression defines a subset of breast cancer and confers sensitivity to losartan, an AGTR1 antagonistA conceptually new treatment approach for relapsed glioblastoma: coordinated undermining of survival paths with nine repurposed drugs (CUSP9) by the International Initiative for Accelerated Improvement of Glioblastoma CareRole and therapeutic potential of G-protein coupled receptors in breast cancer progression and metastasesBlockage of angiotensin II type I receptor decreases the synthesis of growth factors and induces apoptosis in C6 cultured cells and C6 rat gliomaAngiotensin I-converting enzyme and potential substrates in human testis and testicular tumours.Transcriptional network analysis reveals that AT1 and AT2 angiotensin II receptors are both involved in the regulation of genes essential for glioma progression.A Novel Cellular Model to Study Angiotensin II AT2 Receptor Function in Breast Cancer CellsMarketed nonsteroidal anti-inflammatory agents, antihypertensives, and human immunodeficiency virus protease inhibitors: as-yet-unused weapons of the oncologists' arsenal.Manipulating the angiotensin system--new approaches to the treatment of solid tumours.Angiotensin II type 1 receptor expression in ovarian cancer and its correlation with tumour angiogenesis and patient survival.Renin and angiotensinogen expression and functions in growth and apoptosis of human glioblastomaExpression of AT1 and AT2 angiotensin receptors in astrocytomas is associated with poor prognosis.Effect of ANG II on endothelial cell apoptosis and survival and its impact on skeletal muscle angiogenesis after electrical stimulationPharmacology and new perspectives of angiotensin II receptor blocker in prostate cancer treatment.The renin-angiotensin system and malignancy.Angiotensin receptor blockers and angiogenesis: clinical and experimental evidence.Repurposing some older drugs that cross the blood-brain barrier and have potential anticancer activity to provide new treatment options for glioblastoma.Effect of angiotensin system inhibitors on survival in newly diagnosed glioma patients and recurrent glioblastoma patients receiving chemotherapy and/or bevacizumab.Effect of AT1R knockdown on ishikawa cell proliferation induced by estrogen.Acquired platinum resistance enhances tumour angiogenesis through angiotensin II type 1 receptor in bladder cancer.Effect of angiotensin II type 1 receptor antagonist on tumor growth and angiogenesis in a xenograft model of human bladder cancer.Angiotensin II type 1 receptor mRNA and its protein expression in human pancreatic cancer cell lines.Divergent effects of losartan and metoprolol on cardiac remodeling, c-kit+ cells, proliferation and apoptosis in the left ventricle after myocardial infarctionChronic angiotensin II AT1 receptor blockade increases cerebral cortical microvessel density.Prognostic value of renin-angiotensin system blockade in non-muscle-invasive bladder cancer.Steroid-sparing effects of angiotensin-II inhibitors in glioblastoma patients.Impact of Angiotensin-II receptor blockers on vasogenic edema in glioblastoma patients.Hypertension and angiotensin system inhibitors: impact on outcome in sunitinib-treated patients for metastatic renal cell carcinoma.Angiotensins inhibit cell growth in GH3 lactosomatotroph pituitary tumor cell culture: a possible involvement of the p44/42 and p38 MAPK pathways.
P2860
Q24652842-4FF5F653-AC6B-444E-8443-3F987AD39297Q26851160-4C729B24-0E6F-4A5B-A0D6-E7FA95149B68Q28084420-AC654FC7-51D9-4A82-8B76-F7016480978BQ28211260-C54F28B7-A004-40DD-8096-FC21C141336DQ35129506-7149DCAF-129D-4F10-9DF0-2E7F3DC29C5BQ35388346-071B4C62-6CD6-479A-81E0-ED63771DA438Q35609097-63E7809F-222F-4BC6-A6E4-A10FA21CC100Q35653603-7FA49354-9454-4EB0-A74F-3B87EC97889EQ36407240-714B620D-E73C-4968-990C-FF300D48533FQ36613817-B7472793-44A4-4FEC-A447-DCD0ECC72FDCQ36694665-E1A102CB-2315-4DF5-9477-FE4D69DF9B7EQ36755237-08C71406-2721-46FE-BA7F-94AE84965CEFQ36965424-E6640829-B343-419D-B0C8-F7BC89BBF0FBQ37053886-D14C28F7-5F49-4923-A620-C01C8CFDFA6CQ37218569-9BD4AA7A-7751-433E-8692-3F775EE6F6B9Q37864617-8158B589-C7F9-474D-9A11-DE7D52F83AEEQ38587724-FDBDDB62-96B7-40EF-8F91-F39A6A653E3CQ38718044-80D2ECDD-49DF-4CE5-91D7-C063850CD6BCQ39367916-95253C4C-48FC-45AB-8C33-489E080A916EQ39463402-569AD40D-F79C-4BFA-A5C5-0C4995FCE97DQ40132288-0EC27A74-D765-4240-9010-AB22DB08148AQ40478292-BDA0955D-653D-4C38-9062-F2E79CBE806EQ42123922-A9C62ED5-C23C-4887-A6C6-961BCCFC94F8Q46731884-760090E4-02CF-49E2-9233-EAAC9BF7D62DQ47292033-28C8B288-C474-4F0B-AE2D-8B50E646DA09Q48487650-C549E114-3369-4319-BBA7-F33EE4F52859Q49015944-7856EFEA-9EE4-46F7-A8F3-5F9FE0EA81E4Q49134863-59188FE9-AE0F-4EB9-977C-C28A9EF5D512Q53167214-CAA2644B-77FD-4C9C-AEF2-68E036F5E16C
P2860
AT1 receptor is present in glioma cells; its blockage reduces the growth of rat glioma
description
2001 nî lūn-bûn
@nan
2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
AT1 receptor is present in glioma cells; its blockage reduces the growth of rat glioma
@ast
AT1 receptor is present in glioma cells; its blockage reduces the growth of rat glioma
@en
AT1 receptor is present in glioma cells; its blockage reduces the growth of rat glioma
@nl
type
label
AT1 receptor is present in glioma cells; its blockage reduces the growth of rat glioma
@ast
AT1 receptor is present in glioma cells; its blockage reduces the growth of rat glioma
@en
AT1 receptor is present in glioma cells; its blockage reduces the growth of rat glioma
@nl
prefLabel
AT1 receptor is present in glioma cells; its blockage reduces the growth of rat glioma
@ast
AT1 receptor is present in glioma cells; its blockage reduces the growth of rat glioma
@en
AT1 receptor is present in glioma cells; its blockage reduces the growth of rat glioma
@nl
P2093
P2860
P356
P1476
AT1 receptor is present in glioma cells; its blockage reduces the growth of rat glioma
@en
P2093
P2860
P2888
P304
P356
10.1054/BJOC.2001.2102
P407
P577
2001-11-02T00:00:00Z
P5875
P6179
1050739512